Affiliation:
1. Department of Chemical and Biomolecular Engineering, Cullen College of Engineering
2. Department of Clinical Sciences and Administration, College of Pharmacy, University of Houston, Houston, Texas
Abstract
ABSTRACT
Killing by beta-lactams is well known to be reduced against a dense bacterial population, commonly known as the inoculum effect. However, the underlying mechanism of this phenomenon is not well understood. We proposed a semimechanistic mathematical model to account for the reduced
in vitro
killing observed. Time-kill studies were performed with 4 baseline inocula (ranging from approximately 1 × 10
5
to 1 × 10
8
CFU/ml) of
Escherichia coli
ATCC 25922 (MIC, 2 mg/liter). Constant but escalating piperacillin concentrations used ranged from 0.25× to 256× MIC. Serial samples were taken over 24 h to quantify viable bacterial burden, and all the killing profiles were mathematically modeled. The inoculum effect was attributed to a reduction of effective drug concentration available for bacterial killing, which was expressed as a function of the baseline inoculum. Biomasses associated with different inocula were examined using a colorimetric method. Despite identical drug-pathogen combinations, the baseline inoculum had a significant impact on bacterial killing. Our proposed mathematical model was unbiased and reasonable in capturing all 28 killing profiles collectively (
r
2
= 0.88). Biomass was found to be significantly more after 24 h with a baseline inoculum of 1 × 10
8
CFU/ml, compared to one where the initial inoculum was 1 × 10
5
CFU/ml (
P
= 0.002). Our results corroborated previous observations that
in vitro
killing by piperacillin was significantly reduced against a dense bacterial inoculum. This phenomenon can be reasonably captured by our proposed mathematical model, and it may improve prediction of bacterial response to various drug exposures in future investigations.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology